Contents

Current Drug Targets - Inflammation & Allergy, Volume 1 - Number 3

Treatment of Allergic Rhinitis: H1-Antihistamines and Intranasal Steroids

, 1(3): 215 - 220

De-Yun Wang


DOI: 10.2174/1568010023344625




Inflammation and Parkinsons Disease

, 1(3): 221 - 242

Christophe Wersinger and Anita Sidhu


DOI: 10.2174/1568010023344580




Peroxisome Proliferator-Activated Receptors and the Control of Inflammation

, 1(3): 243 - 248

A. Cabrero, J. C. Laguna and M. Vazquez


DOI: 10.2174/1568010023344616




Chlamydial Heat Shock Protein 60 and Lipopolysaccharide: Potential Virulence Determinants in Atherogenesis

, 1(3): 249 - 255

Murat V. Kalayoglu


DOI: 10.2174/1568010023344652




The Mechanisms of Immune-to-Brain Communication in Inflammation as a Drug Target

, 1(3): 257 - 262

Toru Hosoi, Yasunobu Okuma and Yasuyuki Nomura


DOI: 10.2174/1568010023344599




IL-4 and IL-13: Their Pathological Roles in Allergic Diseases and their Potential in Developing New Therapies

, 1(3): 263 - 269

K. Izuhara, K. Arima and S. Yasunaga


DOI: 10.2174/1568010023344661




The Use of Leukotriene Modifying Drugs in Asthma and Other Respiratory Diseases

, 1(3): 271 - 275

J. A. Corless and M. Paracha


DOI: 10.2174/1568010023344643




A Role for Leptin in the Systemic Inflammatory Response Syndrome (SIRS) and in Immune Response

, 1(3): 277 - 289

W. Waelput, P. Brouckaert, D. Broekaert and J. Tavernier


DOI: 10.2174/1568010023344634




Oxidative Stress and Gene Transcription in Asthma and Chronic Obstructive Pulmonary Disease: Antioxidant Therapeutic Targets

, 1(3): 291 - 315

Irfan Rahman


DOI: 10.2174/1568010023344607




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science